| Article Access Statistics|
| Viewed||10261 |
| Printed||267 |
| Emailed||2 |
| PDF Downloaded||149 |
| Comments ||[Add] |
| Cited by others ||2 |
Click on image for details.
|IMAGES IN RADIOLOGY
|Year : 2001 | Volume
| Issue : 2 | Page : 135-6
Pituitary metastases in carcinoma breast.
SR Rao, RS Rao
Shushrusha Hospital, Shivaji Park, Mumbai - 400 028, India. , India
S R Rao
Shushrusha Hospital, Shivaji Park, Mumbai - 400 028, India.
Source of Support: None, Conflict of Interest: None
Keywords: Brain Neoplasms, secondary,Breast Neoplasms, pathology,therapy,Carcinoma, Infiltrating Duct, secondary,Case Report, Combined Modality Therapy, Female, Human, Magnetic Resonance Imaging, Middle Age, Pituitary Neoplasms, secondary,Pleural Effusion, Malignant, pathology,
|How to cite this article:|
Rao S R, Rao R S. Pituitary metastases in carcinoma breast. J Postgrad Med 2001;47:135
A fifty-one-year-old postmenopausal woman presented with a history of an ulcerated lump in the right breast of one-year duration. It was 4 cm x 3 cm in size, in the central quadrant of the right breast. There were no nodes palpable in the right axilla but she had a right supraclavicular node. The left breast and left axilla were normal. Fine needle aspiration cytology confirmed the lesion to be a carcinoma. Her baseline haematological and biochemical investigations, X-ray chest, bone scan and ultrasound abdomen were normal. She received two cycles of neo-adjuvant chemotherapy consisting of CMF regimen (cyclophosphamide, methotrexate, 5-flourouracil). There was partial regression of the tumour. This was followed by a right modified radical mastectomy. The histopathology report was infiltrating duct carcinoma, with 11/11 axillary nodes positive for metastases. Post-operatively, she was put on tamoxifen. She also received further four cycles of chemotherapy (CMF) regimen and radiotherapy (RT) to the breast. She was asymptomatic for two years following radiotherapy.
Two years later, she complained of excessive thirst, and generalised weakness. She had a right-sided pleural effusion, which was confirmed to be malignant on cytology. On admission in the hospital, it was found that her 24-hour urine output was 4000cc. Her serum osmolarity was 253 mos/kg (normal 280-295 mos/kg), and serum sodium, potassium and chloride levels were normal. Her serum antidiuretic hormone level was 2.9 pg/ml, (normal 14 pg/ml). Urine osmolarity was 99 mos./kg (normal 500-800 mos/kg). A magnetic resonance image (MRI) of the brain showed absence of normal luminance of posterior pituitary, oedema and thickening of hypophyseal stalk [Figure - 1]. Posterior pituitary is seen as a bright crescentic shadow in normal subjects [Figure - 2]. There were multiple small metastases in the brain.
She was put on vasopressin by nasal insufflations and received radiotherapy. After radiotherapy her 24-hour urine output came down to normal levels and did not require vasopressin nasal insufflations.
The incidence of metastasis to pituitary in breast cancer is reported as 0.95%.1 Breast cancer and lung cancer are the most common primary sites, in women and men respectively, which metastasise to the pituitary.2 The presenting symptoms include diabetes insipidus, anterior pituitary insufficiency and retro-orbital pain. Metastases to the posterior lobe are more common than to the anterior lobe. The predilection of tumours to metastasise to posterior pituitary may be due to the fact that the neural portion has a blood supply directly from the systemic circulation while the anterior lobe is supplied by the hypothalamus-hypophyseal portal system.1 The clinical manifestation of such a metastasis is diabetes insipidus, which is often the presenting feature. De la Monte et al3 observed that patients who developed endocrine organ metastases were on an average of 5 to 10 years younger than those who had metastases to non-endocrine sites. They proposed that endocrine metastases occur in younger patients because the endocrine organs themselves provide a trophic influence for breast carcinoma cells, which require particular hormones for growth. However this may not be true in all cases. For example our patient was postmenopausal.
A clinical diagnosis of diabetes insipidus is made in the presence of polyuria, polydypsia and in the absence of renal disease, diabetes mellitus, and psychogenic overhydration. Confirmatory tests are serum antidiuretic hormone levels, 24-hour urinary output, specific gravity of urine, plasma osmolarity and urine osmolarity. All the above tests were suggestive of diabetes insipidus in our case.
In the clinical context of a known cancer patient presenting with diabetes insipidus, MRI of the pituitary fossa is very useful in demonstrating metastases to the pituitary., Loss of high signal from the posterior lobe and thickening of the stalk are indicative of infiltration by metastases. The posterior pituitary is not a site that can be readily biopsied and hence the above findings on MRI in a known case of a cancer presenting with diabetes insipidus is taken as evidence of pituitary metastases.
Satisfactory symptomatic relief from diabetes insipidus was achieved in most cases with vasopressin. Efforts should be made to treat the underlying cause rather than mere symptomatic control of diabetes insipidus. Chemotherapy and radiation therapy have been used with variable degree of success. The median length of patient survival following diagnosis of pituitary metastases is 180-days. Aggressive treatment including both surgical decompression and radiation therapy improves the quality of life in patients who are symptomatic.
| :: References|| |
Houck WA, Olson KB, Horton J. Clinical features of tumor metastasis to the pituitary. Cancer 1970; 26:656-659. |
|2.||Teears RJ, Silverman EM. Clinicopathologic review of 85 cases of carcinoma, metastatic to the pituitary gland. Cancer 1975; 36:216-220. |
|3.||de la Monte SM, Hutchins GM, Moore GW. Endocrine organ metastases from breast carcinoma. Am J Pathol 1984; 114:131-136. |
|4.||Yap EY, Tashina CK, Blumenschein GR, Eckles N. Diabetes insipidus and breast cancer. Arch Intern Med 1979; 136:1009-1011. |
|5.||De Merlier Y, Duprez T, Maiter D, Cosnard G. MR features of pituitary metastases in two patients with central diabetes insipidus. Acta Neurol Belg 1996; 96:141-142. |
|6.||Carsin-Nicol B, Carsin M, Gedouin D, Glikstein R, Brassier G. Diabetes insipidus from metastases of hypothalamus-hypophysis axis. Report on 4 cases. J Neuroradiol 1995; 22:43-47. |
|7.||Chaudhuri R, Twelves C, Cox TC, Bingham JB. MRI in diabetes insipidus due to metastatic breast carcinoma. Clin Radiol 1992; 46:184-188.
[Figure - 1], [Figure - 2]
|This article has been cited by|
||Diabetes insipidus and panhypopituitarism revealing pituitary metastasis of small cell lung carcinoma: a case report
| ||Harzallah L, Migaw H, Harzallah F, et al. |
| ||ANNALES D ENDOCRINOLOGIE. 2005; 66 (2): 117-120 |
||Parasellar and suprasellar metastatic lesions: Report of three patients and literature revision
| ||Stoisa, D., De Luca, S.E., Mondello, E.J., Oviedo, J., Lozano, M.P., Casas, G. |
| ||Prensa Medica Argentina. 2004; 91(4): 267-274 |